SpineEX was issued U.S. Patent No. 10,188,527, covering a novel mechanism that allows surgeons to adjust posterior and anterior sides of an interbody fusion device independently of one another.
The company’s intellectual property portfolio includes issued patents in the U.S. and China, with several applications pending in other global regions.
Earlier this week, SpineEX announced additional FDA 510(k) clearance for its Sagittae Lateral Lumbar Interbody Fusion system, supporting advancement of the product to full-scale commercialization.
SpineEX was issued U.S. Patent No. 10,188,527, covering a novel mechanism that allows surgeons to adjust posterior and anterior sides of an interbody fusion device independently of one another.
The company's intellectual property portfolio includes issued patents in the U.S. and China, with several applications pending in other global...
SpineEX was issued U.S. Patent No. 10,188,527, covering a novel mechanism that allows surgeons to adjust posterior and anterior sides of an interbody fusion device independently of one another.
The company’s intellectual property portfolio includes issued patents in the U.S. and China, with several applications pending in other global regions.
Earlier this week, SpineEX announced additional FDA 510(k) clearance for its Sagittae Lateral Lumbar Interbody Fusion system, supporting advancement of the product to full-scale commercialization.
Copy to clipboard 
